LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹394 Cr | ₹346 Cr | ₹295 Cr | ₹262 Cr | ₹233 Cr |
What is the latest Net Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹346 Cr |
| Mar2023 | ₹295 Cr |
| Mar2022 | ₹262 Cr |
| Mar2021 | ₹233 Cr |
How is Net Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹394 Cr | 13.96 | |
| Mar2024 | ₹346 Cr | 17.09 | |
| Mar2023 | ₹295 Cr | 12.47 | |
| Mar2022 | ₹262 Cr | 12.65 | |
| Mar2021 | ₹233 Cr | - | |
Compare Net Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,161.0 Cr | -3% | -7.8% | 4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3% |
-7.8% |
4.1% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses